000 | 01593 a2200481 4500 | ||
---|---|---|---|
005 | 20250512113558.0 | ||
264 | 0 | _c19721012 | |
008 | 197210s 0 0 eng d | ||
022 | _a0009-9236 | ||
024 | 7 |
_a10.1002/cpt1972135part1671 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWeiss, J L | |
245 | 0 | 0 |
_aCardiovascular effects of delta-9-tetrahydrocannabinol in man. _h[electronic resource] |
260 |
_bClinical pharmacology and therapeutics _c |
||
300 |
_a671-84 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBehavior _xdrug effects |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCannabis _xpharmacology |
650 | 0 | 4 | _aCarbon Isotopes |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aDronabinol _xadministration & dosage |
650 | 0 | 4 | _aElectrocardiography |
650 | 0 | 4 |
_aEpinephrine _xurine |
650 | 0 | 4 |
_aForearm _xblood supply |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNorepinephrine _xurine |
650 | 0 | 4 | _aPosture |
650 | 0 | 4 | _aPsychological Tests |
650 | 0 | 4 |
_aRegional Blood Flow _xdrug effects |
650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
700 | 1 | _aWatanabe, A M | |
700 | 1 | _aLemberger, L | |
700 | 1 | _aTamarkin, N R | |
700 | 1 | _aCardon, P V | |
773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 13 _gno. 5 _gp. 671-84 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/cpt1972135part1671 _zAvailable from publisher's website |
999 |
_c4563936 _d4563936 |